Seongjeong Ok, Professor of Pediatrics and Adolescents at Guro Hospital, Korea University.

Seongjeong Ok, Professor of Pediatrics and Adolescents at Guro Hospital, Korea University.

View original image


[Asia Economy Reporter Kim Young-won] Korea University Guro Hospital announced on the 21st that Professor Shim Jeong-ok of the Department of Pediatrics received the Seokcheon Academic Award at the Autumn Academic Conference of the Korean Pediatric Society held on the 20th.


The Seokcheon Academic Award is given in accordance with the wishes of Professor Hong Chang-ui Seokcheon (石泉), who authored the textbook "Pediatrics." It is awarded to one outstanding paper published in domestic and international academic journals and is the most prestigious award presented by the Korean Pediatric Society.


Professor Shim was honored with the award for her paper titled "Nationwide Study on Anti-Tumor Necrosis Factor Therapy Patterns and Prognosis in Korean Pediatric and Adult Inflammatory Bowel Disease," published in the academic journal Alimentary Pharmacology and Therapeutics.


This study revealed that pediatric inflammatory bowel disease in Korea has surged over the past decade and that its severity is higher compared to adults. It also concluded that early prescription of anti-TNF agents results in a better prognosis than delayed prescription in pediatric patients. This is the first study of its kind in non-Western countries.



Professor Shim stated, "Pediatric inflammatory bowel disease is rare compared to adult patients, which poses challenges in research. Despite these difficulties, through the ongoing 'Korean Pediatric Inflammatory Bowel Disease Cohort Study,' we will strive to conduct broad research including elucidating clinical, genetic, and intestinal immune characteristics of pediatric inflammatory bowel disease, as well as diagnosis, treatment, and prognosis prediction."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing